Monopar Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $38.50 on 10/24/24, while the lowest price during the same period was $1.37 on 11/27/23. 52-week price history of
Monopar Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $38.50 on 10/24/24, while the lowest price for the same duration was marked at $1.37 on 11/27/23. 52-week price history of MNPR Stock Studying a
In terms of market performance, Monopar Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $8.65 on 10/24/24, while the lowest value was $1.37 on 11/27/23. 52-week price history of MNPR Stock Analyzing the 52-week price history
The market performance of Monopar Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $8.65 on 02/23/24, with the lowest value for the same timeframe being $1.37, recorded on 11/27/23. 52-week price history of MNPR Stock A
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Monopar Therapeutics Inc’s current trading price is -40.23% away from its 52-week high, while its distance from the 52-week low is 277.51%.
After-hours trading on Monday saw shares of Monopar Therapeutics Inc. (NASDAQ: MNPR) rise 8.78% to $2.23 following the release of encouraging clinical-trial data. What data has MNPR provided? Yesterday, Monopar Therapeutics (MNPR) published encouraging findings with MNPR-202 from its ongoing partnership with the National University
All rights reserved © 2024, Powered By Smart TechOne
